0

Endocrine and Metabolism Collection
 101-120 of 143 Articles
ACP Journal Club |  15 December 2009
Continuous androgen-deprivation therapy increased risk for diabetes and fragility fractures in older men with prostate cancer
Julio Hajdenberg, MD, FACP
Ann Intern Med. 2009;151(12):JC6-14. doi:10.7326/0003-4819-151-12-200912150-02014
ACP Journal Club |  17 November 2009
Use of antipsychotic drugs was associated with increased risk for hyperglycemia in older patients with diabetes
Bradley Ng, MBChB, FRANZCP
Ann Intern Med. 2009;151(10):JC5-12. doi:10.7326/0003-4819-151-10-200911170-02012
ACP Journal Club |  20 October 2009
Adding prompt revascularization to medical therapy did not reduce mortality or CV events in patients with type 2 diabetes and CAD
Paul Poirier, MD, PhD, FRCPC, FACC, FAHA
Ann Intern Med. 2009;151(8):JC4-5. doi:10.7326/0003-4819-151-8-200910200-02005
ACP Journal Club |  20 October 2009
Minimally invasive and conventional glucose monitoring did not differ for long-term glycemic control in insulin-treated diabetes
Sean F. Dinneen, MD; M. Conall Dennedy, MD; Kalpana Muthusamy, MD; et al.
Ann Intern Med. 2009;151(8):JC4-6. doi:10.7326/0003-4819-151-8-200910200-02006
ACP Journal Club |  20 October 2009
Rosiglitazone was noninferior to metformin plus sulfonylurea for CV events but increased risk for HF and fractures in type 2 diabetes
Lorraine L. Lipscombe, MD, MSc
Ann Intern Med. 2009;151(8):JC4-8. doi:10.7326/0003-4819-151-8-200910200-02008
ACP Journal Club |  15 September 2009
Accessing preappraised evidence: fine-tuning the 5S model into a 6S model
Alba DiCenso, RN, PhD; Liz Bayley, MLS; R. Brian Haynes, MD, PhD
Ann Intern Med. 2009;151(6):JC3-2. doi:10.7326/0003-4819-151-6-200909150-02002
ACP Journal Club |  15 September 2009
Review: Intensive glucose control reduced some CV events but did not change mortality in type 2 diabetes
Lorraine L. Lipscombe, MD, MSc, FRCPC
Ann Intern Med. 2009;151(6):JC3-6. doi:10.7326/0003-4819-151-6-200909150-02006
ACP Journal Club |  18 August 2009
Review: Intensive insulin therapy increases risk for hypoglycemia but not mortality in critically ill adults
Michelle A. Kovalaske, MD; Gunjan Y. Gandhi, MD, MSc
Ann Intern Med. 2009;151(4):JC2-4. doi:10.7326/0003-4819-151-4-200908180-02004
ACP Journal Club |  18 August 2009
Review: Diabetes is not a coronary disease equivalent
Michael E. Farkouh, MD
Ann Intern Med. 2009;151(4):JC2-6. doi:10.7326/0003-4819-151-4-200908180-02006
ACP Journal Club |  18 August 2009
Screening for CAD in asymptomatic patients with type 2 diabetes did not reduce risk for cardiac events
Michael E. Farkouh, MD
Ann Intern Med. 2009;151(4):JC2-7. doi:10.7326/0003-4819-151-4-200908180-02007
ACP Journal Club |  18 August 2009
Review: Aldosterone blockade reduces mortality in patients with left ventricular dysfunction
Peter Liu, MD
Ann Intern Med. 2009;151(4):JC2-9. doi:10.7326/0003-4819-151-4-200908180-02009
ACP Journal Club |  18 August 2009
Bariatric surgery was cost-effective at 2 years for management of type 2 diabetes in obese patients
Scott Kahan, MD, MPH
Ann Intern Med. 2009;151(4):JC2-14. doi:10.7326/0003-4819-151-4-200908180-02014
ACP Journal Club |  18 August 2009
Bariatric surgery was dominant over conventional therapy for lifetime management of type 2 diabetes in obese patients
Scott Kahan, MD, MPH
Ann Intern Med. 2009;151(4):JC2-15. doi:10.7326/0003-4819-151-4-200908180-02015
ACP Journal Club |  21 July 2009
Adding metformin to insulin did not improve a composite of microvascular and macrovascular disease in type 2 diabetes
Vivian Fonseca, MD
Ann Intern Med. 2009;151(2):JC1-12. doi:10.7326/0003-4819-151-2-200907210-02012
ACP Journal Club |  19 May 2009
Intensive primary care treatment reduced cardiovascular risk factors at 1 year in screen-detected type 2 diabetes
C. Raina Elley, MD; Tim Kenealy, MD, PhD
Ann Intern Med. 2009;150(10):JC5-9. doi:10.7326/0003-4819-150-10-200905190-02009
ACP Journal Club |  21 April 2009
Review: Metformin reduces risk for CV mortality compared with other oral diabetes drugs or placebo in type 2 diabetes
Lorraine Lipscombe, MD, MSc, FRCPC
Ann Intern Med. 2009;150(8):JC4-8. doi:10.7326/0003-4819-150-8-200904210-02008
ACP Journal Club |  21 April 2009
Review: Oral drugs for gestational diabetes do not increase adverse maternal and neonatal outcomes more than insulin
Denice Feig, MD
Ann Intern Med. 2009;150(8):JC4-9. doi:10.7326/0003-4819-150-8-200904210-02009
ACP Journal Club |  17 March 2009
Intensive and standard glucose control did not differ for major CV events or death in poorly controlled type 2 diabetes
Gillian L. Booth, MD, MSc
Ann Intern Med. 2009;150(6):JC3-8. doi:10.7326/0003-4819-150-6-200903170-02008
ACP Journal Club |  17 February 2009
Intensive insulin therapy reduced long-term risk for incident hypertension in type 1 diabetes
Apostolos Tsapas, MD, PhD
Ann Intern Med. 2009;150(4):JC2-12. doi:10.7326/0003-4819-150-4-200902170-02012
ACP Journal Club |  20 January 2009
Aspirin and/or antioxidants did not prevent CV events in diabetes and peripheral arterial disease
Michael E. Farkouh, MD, MSc
Ann Intern Med. 2009;150(2):JC1-8. doi:10.7326/0003-4819-150-2-200901200-02008
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)